Patent: 8,708,968
✉ Email this page to a colleague
Summary for Patent: 8,708,968
| Title: | Removal of needle shields from syringes and automatic injection devices |
| Abstract: | Exemplary embodiments provide a needle shield remover that reliably engages with a distal cap of an automatic injection device and with one or more needle shields coupled to a syringe of the device. When a user removes the distal cap, the needle shield remover reliably removes the needle shields (e.g., a soft needle shield and a rigid needle shield) from the syringe, thereby exposing the injection needle for performing an injection. In an exemplary assembly method, a needle shield remover is engaged to a needle shield coupled to a syringe, prior to insertion of the syringe and needle shield remover assembly into a housing of the device. This exemplary assembly method allows visual inspection, outside the housing of the device, to ensure that the needle shield remover is correctly and reliably engaged to the needle shield before the syringe and needle shield remover assembly is inserted into the housing. |
| Inventor(s): | Julian Joseph F., Li Chuan, Anderson Philip D., Laurusonis Linas P., Raday Lior, Carmel Ehud, Marli Lior, Daily David, Keenan Guy |
| Assignee: | Abbvie Biotechnology Ltd. |
| Application Number: | US13357508 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,708,968
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | December 31, 2002 | ⤷ Sign Up | 2032-01-24 |
| Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | February 21, 2008 | ⤷ Sign Up | 2032-01-24 |
| Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | April 24, 2013 | ⤷ Sign Up | 2032-01-24 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
